PAM
MNTA

Panagora Asset Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Panagora Asset Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,786
Closed -$94K – 3137
2020
Q3 		$94K Buy
+1,786
New +$73.9K ﹤0.01% 1815
2018
Q2 		– Sell
-69,529
Closed -$1.26M – 2452
2018
Q1 		$1.26M Sell
69,529
-184,305
-73% -$3.07M 0.01% 1072
2017
Q4 		$3.54M Buy
253,834
+1,502
+0.6% +$20.3K 0.01% 654
2017
Q3 		$4.67M Buy
252,332
+9,500
+4% +$159K 0.02% 596
2017
Q2 		$4.1M Buy
+242,832
New +$3.7M 0.02% 625
2016
Q4 		– Sell
-6,445
Closed -$75K – 2446
2016
Q3 		$75K Buy
6,445
+723
+13% +$8.5K ﹤0.01% 2034
2016
Q2 		$62K Sell
5,722
-1,785
-24% -$18.4K ﹤0.01% 2022
2016
Q1 		$69K Buy
+7,507
New +$80.8K ﹤0.01% 1955
2015
Q3 		– Sell
-879
Closed -$20K – 2477
2015
Q2 		$20K Buy
+879
New +$17.5K ﹤0.01% 2307

Panagora Asset Management's MNTA Position: Q4 2020 in Review

Panagora Asset Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 1,786 shares — an estimated $94K sold.

Panagora Asset Management first reported a position in MNTA in Q2 2015 and held it in 9 quarters. The position peaked at $4.67M in Q3 2017. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Panagora Asset Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Panagora Asset Management sold 1,786 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $94K.
  • Panagora Asset Management first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2015 and held it in 9 quarters.
  • Panagora Asset Management's Momenta Pharmaceuticals, Inc. position peaked at $4.67M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Panagora Asset Management's 13F filing for Q4 2020, filed 10 Feb 2021.